Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Dow
Queensland Health
Citi
Cipla
Covington
Medtronic
Daiichi Sankyo

Generated: December 14, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040189

« Back to Dashboard

NDA 040189 describes METHYLPREDNISOLONE, which is a drug marketed by Elkins Sinn, Organon Usa Inc, Duramed Pharms Barr, Heather, Jubilant Cadista, Par Pharm, Sandoz, Tianjin Tianyao, Vintage Pharms, Watson Labs, Zydus Pharms Usa Inc, Akorn, Sagent Pharms, Sandoz Inc, Teva Pharms Usa, Abraxis Pharm, Amneal Pharms Co, Aurobindo Pharma Ltd, Bedford Labs, Fresenius Kabi Usa, Hikma Farmaceutica, Intl Medication, and Teva Parenteral, and is included in fifty-eight NDAs. It is available from twenty-six suppliers. Additional details are available on the METHYLPREDNISOLONE profile page.

The generic ingredient in METHYLPREDNISOLONE is methylprednisolone acetate. There are forty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
Summary for 040189
Tradename:METHYLPREDNISOLONE
Applicant:Jubilant Cadista
Ingredient:methylprednisolone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 040189
Medical Subject Heading (MeSH) Categories for 040189
Suppliers and Packaging for NDA: 040189
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHYLPREDNISOLONE methylprednisolone TABLET;ORAL 040189 ANDA KAISER FOUNDATION HOSPITALS 0179-0124 0179-0124-70 30 TABLET in 1 BOX, UNIT-DOSE (0179-0124-70)
METHYLPREDNISOLONE methylprednisolone TABLET;ORAL 040189 ANDA Rebel Distributors Corp. 21695-080 21695-080-21 21 TABLET in 1 BOTTLE (21695-080-21)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG
Approval Date:Oct 31, 1997TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength8MG
Approval Date:Oct 31, 1997TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength16MG
Approval Date:Jul 20, 2007TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chubb
Fuji
Chinese Patent Office
Federal Trade Commission
Dow
Express Scripts
Healthtrust
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.